Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hua Li

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|December 27, 2016
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Alie H Wurie, Li-Hua Hou, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2020
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled StudyYing-Jun Chang, De-Pei Wu, Yong-Rong Lai, et al.
Bone Marrow Transplantation|December 2, 2024
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter studyJie Sun, Yi-Cheng Zhang, Jia Wei, et al.
Vaccine|November 4, 2023
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adultsGui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, et al.
Lancet (London, England)|July 24, 2020
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
Bone Marrow Transplantation|November 26, 2024
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter studyJian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2025
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory StudyFeng-Qi Liu, Zhuo-Yu An, Li-Juan Cui, et al.
International Journal of Cancer|May 26, 2025
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world studyYu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|December 27, 2016
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Alie H Wurie, Li-Hua Hou, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2020
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled StudyYing-Jun Chang, De-Pei Wu, Yong-Rong Lai, et al.
Bone Marrow Transplantation|December 2, 2024
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter studyJie Sun, Yi-Cheng Zhang, Jia Wei, et al.
Vaccine|November 4, 2023
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adultsGui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, et al.
Lancet (London, England)|July 24, 2020
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
Bone Marrow Transplantation|November 26, 2024
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter studyJian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2025
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory StudyFeng-Qi Liu, Zhuo-Yu An, Li-Juan Cui, et al.
International Journal of Cancer|May 26, 2025
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world studyYu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, et al.
Pageof 19